Advertisement

Deadline for NIAID BAA Proposals: Development of Radiation/Nuclear Medical Countermeasures

Global Biodefense Calendar

Research Area 001: Development of Radiation/Nuclear Medical Countermeasures (MCMs) HHS-NIH-NIAID-BAA2020-1 This research topic call for proposals is part of the 2020 NIAID Omnibus Broad Agency Announcement. It supports the development of safe and effective MCMs to mitigate and/or treat tissue injuries resulting from exposure to ionizing radiation from a radiological or nuclear incident, thereby leading

Deadline for NIAID BAA Proposals: Therapeutic Products for Biodefense, AMR Infections, and Emerging Infectious Diseases

Global Biodefense Calendar

HHS-NIH-NIAID-BAA2020-1 Research Area 004: Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections, and Emerging Infectious Diseases Supports development of promising new therapeutics to address infections caused by NIAID Category A, B, and C priority pathogens and select bacterial and fungal infections identified in CDC’s report Antibiotic Resistance Threats in the United States 2019 , including optimization, preclinical

Deadline for NIAID BAA Proposals: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases

Global Biodefense Calendar

HHS-NIH-NIAID-BAA2020-1 Research Area 003: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Supports development of vaccines 1) to address antibiotic resistant gram-negative bacteria focusing on but not limited to Burkholderia spp., Pseudomonas aeruginosa, Francisella tularensis, Yersinia pestis, and E. coli, and 2) for emerging viruses and pandemic preparedness that includes but is not limited to alphaviruses

Deadline for NIAID BAA Proposals: Advanced Development of Diagnostics for Biothreats and EID

Global Biodefense Calendar

HHS-NIH-NIAID-BAA2020-1 Research Area 005: Advanced Development of Diagnostics for Biothreats and Emerging Infectious Diseases Supports advancing the development of novel, rapid sample-to-answer candidate diagnostic products that will address biodefense and pandemic preparedness. Number of Awards/Total Costs: NIAID estimates that one or more awards may be issued for this Research Area for a total cost of up

Protecting Older Adults from the Harms of Social Isolation and Providing a Continuum of Care During COVID-19

Virtual Event Virtual Event

Join Trust for America's Health (TFAH) on Wednesday, April 15th for the webinar Protecting Against the Harms of Social Isolation During COVID-19. The ongoing COVID-19 crisis presents unique challenges for the public health and aging sectors. While social distancing protects older adults who are at higher risk for complications from the virus, the practice can

APHA and National Academy of Medicine Webinar: Crisis Standards of Care During COVID-19

Virtual Event Virtual Event

Brought to you by the American Public Health Association and the National Academy of Medicine, this webinar series is exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts

POSTPONED | NO NEW DATE – BSL-4 Training: Achieving Data Quality and Integrity in Maximum Containment Laboratories

National Institutes of Health (NIH) Bethesda, MD, United States

The FDA and the University of Texas Medical Branch, Galveston National Laboratory (UTMB) will host this year's annual training course on how to meet GLP requirements in BSL-4 facilities from April 20-24, 2020 at the National Institutes of Health (NIH) in Bethesda, Maryland. Scientists working to develop Medical Countermeasures (MCMs) against several high-priority biological threat agents are

Free

DASA Biosensing Across Wide Areas Phase 2 Launch

Virtual Event Virtual Event

Join the Defence and Security Accelerator for a dial-in on 21 April 2020, 1pm to 2pm. The competition team will provide a short briefing on the Biosensing Across Wide Areas Phase 2 competition followed by an open forum Q&A session. One to Ones There will be two opportunities for One to One dial-in sessions with

Quickfire Challenge Applications Due: JLABS Pediatric Influenza Innovations

Global Biodefense Calendar

Innovators within the fields of pediatric oncology, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150,000 in grant funding; one year of residency at JLABS @ Washington, DC with the use of a bench, workstation, and access to the JLABS @ Washington, DC community; and mentorship from